Advancing Revolutionary Therapies

Advancing Revolutionary Therapies

Por: ART
Cell and gene therapies have made impressive clinical progress but continue to face big hurdles. Nothing is standard about study design, study conduct or regulatory process in this specialized area.
26 episodios disponibles

Latest episodes of the podcast Advancing Revolutionary Therapies

The influence of MDR’s Article 117 in the Marketing of Combination Products 08/02/2023
Apples to Apples: Playing the Comparability Game in Biotherapeutics Development 24/01/2023
Considerations for Developing Rare Disease Treatments 15/12/2022
Regulatory Considerations for Biosimilars Development in the U.S. 06/12/2022
The Importance of Regulatory Project Management 15/11/2022
CMC Pitfalls: From Benchtop to IND 31/10/2022
Marketing Application Best Practices for Publishing 17/10/2022
Emergency Use Authorizations 22/09/2022
Orphan Drug Designations and Orphan Subsets 11/09/2022
Season 3 Trailer 26/08/2022
Reasons for Setting Up Natural History Studies & Their Challenges 18/05/2022
The Current Landscape of Cell and Gene Therapies and Where We are Headed 27/04/2022
Use of PRO In Cell and Gene Therapy Studies 13/04/2022
Real-world Considerations When Administering Advanced Therapy Products 30/03/2022
Planning the Way Forward in Neurodegenerative Disease Studies 16/03/2022
Opportunities for Virtual and Central Site Models in Cell and Gene Therapy Trials 03/03/2022
An Introduction to Natural History Studies 17/02/2022
Common pitfalls to avoid when planning a marketing application for cell and gene therapies 02/02/2022
Season 2 Trailer 25/01/2022
Are Autologous Therapies Here to Stay? Are Allogeneic Therapies the Future? 16/12/2021
1 2 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA